David S. Kabakoff
CIK: 0001024008
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NXTC
NextCure, Inc.
Director
Discretionary Trading P&L
Holdings
About KABAKOFF DAVID S
KABAKOFF DAVID S (SEC CIK 0001024008) files insider reports with the SEC as Director of NextCure, Inc. (NXTC).
Signal8 holds 2 ownership filings by KABAKOFF DAVID S, all Form 4s, filed between Jun 24, 2025 and Jun 22, 2026. Those filings report 2 transactions, from Jun 20, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on KABAKOFF DAVID S's filings is in BELTSVILLE, MD.
Recent filings by KABAKOFF DAVID S
Other insiders filing for NextCure, Inc. (NXTC)
- ADAR1 Capital Management, LLC, 10% Owner
- Simcere Zaiming, Inc., Officer
- Feigal Ellen, Director
- Jones Elaine V, Director
- Borgman Anne Elizabeth, Director
- Webster Stephen W, Director